Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Citi
AstraZeneca
Chubb
Johnson and Johnson
Fish and Richardson
Federal Trade Commission
Queensland Health
US Army
Boehringer Ingelheim

Generated: December 12, 2017

DrugPatentWatch Database Preview

AREDIA Drug Profile

« Back to Dashboard

Which patents cover Aredia, and when can generic versions of Aredia launch?

Aredia is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in AREDIA is pamidronate disodium. There are five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pamidronate disodium profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
NovartisAREDIApamidronate disodiumINJECTABLE;INJECTION020036-001Oct 31, 1991DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
NovartisAREDIApamidronate disodiumINJECTABLE;INJECTION020036-003May 6, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
NovartisAREDIApamidronate disodiumINJECTABLE;INJECTION020036-004May 6, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: AREDIA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
NovartisAREDIApamidronate disodiumINJECTABLE;INJECTION020036-001Oct 31, 1991► Subscribe► Subscribe
NovartisAREDIApamidronate disodiumINJECTABLE;INJECTION020036-004May 6, 1993► Subscribe► Subscribe
NovartisAREDIApamidronate disodiumINJECTABLE;INJECTION020036-003May 6, 1993► Subscribe► Subscribe
NovartisAREDIApamidronate disodiumINJECTABLE;INJECTION020036-004May 6, 1993► Subscribe► Subscribe
NovartisAREDIApamidronate disodiumINJECTABLE;INJECTION020036-003May 6, 1993► Subscribe► Subscribe
NovartisAREDIApamidronate disodiumINJECTABLE;INJECTION020036-001Oct 31, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Cipla
Daiichi Sankyo
Covington
UBS
Fuji
Julphar
Harvard Business School
Mallinckrodt
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot